India Minimally Invasive Biopsy Techniques Market to Grow with a CAGR of 10.77% through 2030
Increasing
awareness and early diagnosis is expected to drive the India Minimally Invasive
Biopsy Techniques Market growth in the forecast period, 2026-2030.
According to
TechSci Research report, “India Minimally Invasive Biopsy Techniques Market -
By Region, Competition, Forecast & Opportunities, 2030F”, the India
Minimally Invasive Biopsy Techniques Market stood at USD 89.31 Million in 2024
and is anticipated to grow with a CAGR of 10.77% through 2030. The Indian
government has launched several initiatives to enhance early cancer detection,
healthcare accessibility, and diagnostic advancements, fueling the growth of
the Minimally Invasive Biopsy Techniques Market. Ayushman Bharat-Pradhan Mantri
Jan Arogya Yojana (AB-PMJAY) provides free cancer screening and treatment for
millions, ensuring better access to diagnostic services. The National Cancer
Control Programme (NCCP) focuses on preventive strategies, early detection, and
infrastructure development to combat the rising cancer burden. T
he National
Digital Health Mission (NDHM) is improving patient data management and remote
diagnostics, accelerating the adoption of liquid biopsies and image-guided
techniques. The Make in India initiative is also encouraging domestic
production of biopsy instruments and consumables, reducing dependency on
imports. Moreover, increased funding for AI-driven diagnostics and
public-private partnerships are driving technological advancements, making
minimally invasive biopsy techniques more accessible and efficient across
India.
The growing
awareness about cancer and the importance of early diagnosis is a key driver of
the Minimally Invasive Biopsy Techniques Market in India. With rising cancer
cases—one in nine Indians likely to develop cancer in their lifetime—there is
an increasing emphasis on early detection to improve survival rates. Awareness
campaigns by government bodies, healthcare institutions, and non-profit
organizations have played a significant role in educating the public about the
benefits of regular screenings and advanced diagnostic techniques.
Initiatives such
as the National Cancer Awareness Day, the Ayushman Bharat program, and the
National Cancer Grid have helped promote preventive healthcare measures and
routine check-ups, leading to higher demand for minimally invasive biopsy
techniques. The Indian Council of Medical Research (ICMR) and the
National Health Mission (NHM) have strengthened cancer registry programs,
ensuring improved cancer surveillance and early intervention strategies.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "India Minimally Invasive Biopsy Techniques Market”
The India
Minimally Invasive Biopsy Techniques Market is segmented into product, technique,
circulating biomarker, application, end user, regional distribution, and
company.
Based
on Product, Instruments have emerged as the fastest growing segment in the India
Minimally Invasive Biopsy Techniques Market in 2024, driven by technological
advancements, increasing adoption of image-guided procedures, and rising demand
for precision diagnostics. The growing burden of cancer cases, coupled with
expanding healthcare infrastructure, has fueled the need for biopsy needles,
vacuum-assisted biopsy devices, and robotic-assisted systems.
Based on Region,
South India have emerged as the fastest growing region in the India Minimally
Invasive Biopsy Techniques Market in 2024. This growth is driven by expanding healthcare
infrastructure, the presence of leading cancer research institutes, and
increasing government investments in diagnostic advancements. States like
Tamil Nadu, Karnataka, Telangana, and Kerala are witnessing rapid adoption of
minimally invasive biopsy technologies, supported by high-tech medical
facilities, a strong private healthcare sector, and rising awareness of early
cancer detection. Medical tourism, AI-driven diagnostic
innovations, and the growing presence of top-tier hospitals have further fueled
market expansion in this region.
Major companies
operating in India Minimally Invasive Biopsy Techniques Market are:
- Hoffmann-La
Roche AG
- Thermo
Fisher Scientific, Inc.
- PerkinElmer
Inc.
- QIAGEN
India Pvt. Ltd.
- Cardinal
Health International India Pvt Ltd
- B.
Braun SE
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The field of
biopsy procedures has undergone remarkable progress, enhancing accuracy,
efficiency, and patient comfort. The adoption of image-guided techniques, such
as ultrasound-guided, MRI-guided, and CT-guided biopsies, has significantly
improved the precision of tissue sampling, reducing the need for repeat
procedures. The emergence of liquid biopsy has transformed cancer
diagnostics by enabling non-invasive detection of circulating tumor DNA
(ctDNA), making early detection and real-time monitoring of cancer more
accessible”, said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“India Minimally Invasive
Biopsy Techniques Market By Product (Tests, Kits & Consumables, Instruments),
By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion
Assays, Others), By Circulating
Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating
Tumor DNA (ctDNA), Extracellular Vesicles, Others), By Application (Clinical,
Therapeutic), By End User (Hospitals & Clinics, Ambulatory Care Center,
Academic & Research Institutions), By Region, Competition, Forecast &
Opportunities, 2020-2030F”, has evaluated the future growth potential of India
Minimally Invasive Biopsy Techniques Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and opportunities
in India Minimally Invasive Biopsy Techniques Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com